On Thursday, March 8, International Women’s Day, Synthesis and Solid State Pharmaceutical Centre (SSPC), a Science Foundation Ireland funded Research Centre officially launched WomenInSSPC (WiSSPC). WiSSPC is a female professional development network formed in response to the under representation of females at post-doctorate level and above in SSPC, and focussed on supporting the progression of female researchers in research and academia.
Dublin, 26th February 2018 – Minister for Training, Skills, Innovation, Research and Development, John Halligan TD, announced the first five awards of the Science Foundation Ireland Science Policy Research Programme, with an investment of €2.8 million. The selected research projects comprise studies of: the role of talent and human capital management in national science foundations; the economic and societal impacts of scientific research; the link between scientific knowledge production and technological progress; the peer review process; and the importance of star researchers.
On Thursday, February 22, Professor Michael Zaworotko, Director of Synthesis and Solid State Pharmaceutical Centre (SSPC), announced the (Bio) Pharma Europe working group at BioPharma Ambition 2018. (Bio) Pharma Europe, an extension of Bio (Pharma) Ireland, is an inclusive industry/academia partnership working to create a more innovative environment for pharmaceutical manufacturing in Europe (both small and large molecule).
The project will explore continuous crystallization of an Active Pharmaceutical Ingredient with an integrated wet mill using closed loop control and online Process Analytical Techniques (PAT). The initial phase of the project will involve selection of a suitable model API system to work with, characterisation of the experimental set up (Mettler Toledo Optimax with IKA Magic Mill; potential for additional vessel with heating and agitation control), and integration of Perceptive Engineering’s PharmaMV software platform. PAT measurements such as Focused Beam Reflectance Measurement (FBRM) and Infrared Spectrometry will be used to monitor product quality in-situ.
As part of their structured PhD programme, NUI Galway’s School of Chemistry, in association with SSPC in UL, are providing a 2-day course on the development and scale-up of organic syntheses for the commercial manufacture of drug substances. Focus on synthetic processes for “small molecule” active drug ingredients (APIs) and address the organic, physical and analytical chemistry involved. The course will cover process selection and development, technology transfer and on-going optimisation with reference to the safety, environmental, engineering, quality and regulatory disciplines involved. Use real examples to illustrate the subject.
The course will be delivered by Industrial practitioners and is aimed at PhD students in chemistry and related disciplines. There will be a fee of €100 for non-NUIG attendees. Applications to email@example.com (087-6775481).